: FDA updates authorization of BioNTech, Pfizer’s bivalent booster for young children


The Food and Drug Administration on Tuesday said children between the ages of 6 months and 5 years old can now get a booster dose of BioNTech BNTX, -0.64% and Pfizer’s PFE, -0.55% COVID-19 bivalent vaccine. The third shot should come no sooner than two months after the primary series of three shots. It’s for children who received the primary series of three original shots. (Since December, some children could get a bivalent shot as the third injection in the primary series.)

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: Credit Suisse shares tumble to new record low as European banking sector reels
Next articleU.S. retail sales decline in February


Please enter your comment!
Please enter your name here